Articles by Adeline Siew, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Adeline Siew, PhD

The Importance of Characterization in Biosimilars Development

Industry experts discuss the requirements and challenges involved in getting a biosimilar product from bench to launch.
Sep 2, 2013

Industry experts discuss the requirements and challenges involved in getting a biosimilar product from bench to launch.

Gauging the Outlook of the Biologics Market

A Q&A with Mike Jenkins, Catalent
Sep 2, 2013

Mike Jenkins, general manager of Catalent Biologics discusses the evolving landscape of the biologics market and hurdles faced in the development and manufacture of these innovative products.

MHRA Warns of Dangerous Traditional Chinese Medicines

The MHRA has issued a warning to the public not to use unlicensed traditional Chinese medicines after discovering that some of them contain dangerously high levels of lead, mercury and arsenic.
Aug 22, 2013

The MHRA has issued a warning to the public not to use unlicensed traditional Chinese medicines after discovering that some of them contain dangerously high levels of lead, mercury and arsenic.

ABPI Sets Guidelines on Clinical Trial Disclosure

ABPI toolkit provides guidance to pharmaceutical companies on how to meet clinical trial transparency requirements
Aug 16, 2013

ABPI toolkit provides guidance to pharmaceutical companies on how to meet clinical trial transparency requirements

Rx-360 Advances Supply-Chain Security

Rx-360, a pharmaceutical industry supply-chain consortium, is advancing approaches between pharmaceutical companies, suppliers, and contract manufacturers to better secure the pharmaceutical supply chain.
Aug 1, 2013

Rx-360, a pharmaceutical industry supply-chain consortium, is advancing approaches between pharmaceutical companies, suppliers, and contract manufacturers to better secure the pharmaceutical supply chain.

Implications for APIs in the European Falsified Medicines Directive

Two industry groups offer perspectives on The European Falsified Medicines Directive.
Aug 1, 2013

Industry groups offered perspectives on the strengths and weaknesses of the European Falsified Medicines Directive.

Scientists Discover New Targets for Breast Cancer

Scientists at A*STAR's Genome Institute of Singapore (GIS) have identified genes that could be potential targets for anticancer agents in the treatment of aggressive breast cancer.
Jul 29, 2013

Scientists at A*STAR's Genome Institute of Singapore (GIS) have identified genes that could be potential targets for anticancer agents in the treatment of aggressive breast cancer.

Adaptimmune Initiates Phase I/IIa Clinical Trial in Ovarian Cancer

Adaptimmune has opened a Phase I/IIa ovarian cancer trial to evaluate its genetically engineered T cell treatment, with enhanced antitumor activity.
Jul 26, 2013

Adaptimmune has opened a Phase I/IIa ovarian cancer trial to evaluate its genetically engineered T cell treatment, with enhanced antitumor activity.

CPhI Pharma Insights: Formulation and Ingredients Report

The report highlights a need for greater third party certification to ensure GMP vigilance.
Jul 25, 2013

The report highlights a need for greater third party certification to ensure GMP vigilance.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here